Results 161 to 170 of about 45,216 (237)

Stromal cell effects on melanoma cell drug response [PDF]

, 2013
Thesis (M.A.)--Boston UniversityObjective: Melanoma is currently one of the deadliest forms of skin disease in the United States. However in the past decade there have been significant advances in treatment.
Della Penna, Greg
core   +1 more source

MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24

, 2023
Zongqiang Hu, Yingpeng Zhao, Yuanyi Mang, Jiashun Zhu, Lu Yu, Li Li, Jianghua Ran   +6 more
openalex   +1 more source

COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma

Advanced Science
Sorafenib, which is proven to serve as a potent ferroptosis inducer, is used as a first‐line treatment for patients with advanced hepatocellular carcinoma (HCC), but it has limited clinical benefits, mainly due to drug resistance.
Ai‐Ling Luo, Wen‐Ying Zheng, Qiong Zhang, Yan Yuan, Mei‐Qi Li, Kai Du, An‐Ran Gao, Li‐Jun Pei, Jie Xie, Wen‐Hao Chen, Long Zhang, Xiu‐Zhu Guo, Xiao‐Ran Yang, Chao Zeng, Guo‐Hua Yang, Min Deng   +15 more
doaj   +1 more source

Data from Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression

, 2023
Chiun Hsu, Liang‐In Lin, Yu‐Che Cheng, Zi-Rui Feng, Yu‐Yun Shao, Ann‐Lii Cheng, Da‐Liang Ou   +6 more
openalex   +1 more source

Erratum to miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1 [PDF]

, 2022
Editorial Office
openalex   +1 more source

CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma. [PDF]

Int J Med Sci
Zhuo W, Zhao J, Zheng Z, Cai S, Zeng G, Lin E, Bai Z, Wang B, Jia Y, Li P, Li J.   +10 more
europepmc   +1 more source

SLC25A39 regulates Hedgehog signaling to promote tumor progression and sorafenib resistance in hepatocellular carcinoma. [PDF]

Sci Rep
Qiu Q, Yin H, Zhang L, Xu W, Zhu S, Zhang Q, Zhao M, Qian Y, Ruan Y, Zhang H, Wu Z, Liu J, Ke J, Dai Y, Wang W, Sun W, Gao Y, Xu H.   +17 more
europepmc   +1 more source

Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model. [PDF]

Discov Oncol
He K, Hui H, Zhou F, Liu K, Zhao X, Liu J.   +5 more
europepmc   +1 more source

FBXO2 promotes hepatocellular carcinoma progression and sorafenib resistance by targeting USP49 for proteasomal degradation. [PDF]

Front Immunol
Hang S, Wang Q, Zhang J, Dong Y, Hu B, Wang P, Xu L.   +6 more
europepmc   +1 more source

Targeted therapy in melanoma [PDF]

, 2009
Tawbi,
core   +1 more source